BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32502942)

  • 1. Per- and polyfluoroalkyl substances in blood plasma - Results of the German Environmental Survey for children and adolescents 2014-2017 (GerES V).
    Duffek A; Conrad A; Kolossa-Gehring M; Lange R; Rucic E; Schulte C; Wellmitz J
    Int J Hyg Environ Health; 2020 Jul; 228():113549. PubMed ID: 32502942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
    Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
    Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.
    Daly ER; Chan BP; Talbot EA; Nassif J; Bean C; Cavallo SJ; Metcalf E; Simone K; Woolf AD
    Int J Hyg Environ Health; 2018 Apr; 221(3):569-577. PubMed ID: 29514764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.
    Calafat AM; Wong LY; Kuklenyik Z; Reidy JA; Needham LL
    Environ Health Perspect; 2007 Nov; 115(11):1596-602. PubMed ID: 18007991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014.
    Ye X; Kato K; Wong LY; Jia T; Kalathil A; Latremouille J; Calafat AM
    Int J Hyg Environ Health; 2018 Jan; 221(1):9-16. PubMed ID: 28993126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human biomonitoring (HBM)-II values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) - Description, derivation and discussion.
    Schümann M; Lilienthal H; Hölzer J
    Regul Toxicol Pharmacol; 2021 Apr; 121():104868. PubMed ID: 33484797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children's exposure to perfluoroalkyl acids - a modelling approach.
    Balk FGP; Winkens Pütz K; Ribbenstedt A; Gomis MI; Filipovic M; Cousins IT
    Environ Sci Process Impacts; 2019 Nov; 21(11):1875-1886. PubMed ID: 31549993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluorinated substances in the Flemish population (Belgium): Levels and determinants of variability in exposure.
    Colles A; Bruckers L; Den Hond E; Govarts E; Morrens B; Schettgen T; Buekers J; Coertjens D; Nawrot T; Loots I; Nelen V; De Henauw S; Schoeters G; Baeyens W; van Larebeke N
    Chemosphere; 2020 Mar; 242():125250. PubMed ID: 31896205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women.
    Zhang S; Tan R; Pan R; Xiong J; Tian Y; Wu J; Chen L
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2543-2551. PubMed ID: 29986037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of 3M Cordova, IL production worker's per- and polyfluoroalkyl substances biomonitoring results and mortality experience.
    Andres KL; Olsen GW; Krisko RM; Nunnally MC; Boeding RR; Leniek KL; Taiwo OA
    Int J Hyg Environ Health; 2024 Mar; 256():114321. PubMed ID: 38244249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
    Kang H; Kim SH
    Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using 2003-2014 U.S. NHANES data to determine the associations between per- and polyfluoroalkyl substances and cholesterol: Trend and implications.
    Dong Z; Wang H; Yu YY; Li YB; Naidu R; Liu Y
    Ecotoxicol Environ Saf; 2019 May; 173():461-468. PubMed ID: 30798190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Biomonitoring (HBM)-I values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) - Description, derivation and discussion.
    Hölzer J; Lilienthal H; Schümann M
    Regul Toxicol Pharmacol; 2021 Apr; 121():104862. PubMed ID: 33444659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Per- and polyfluoroalkyl substances (PFAS) in Australia: Current levels and estimated population reference values for selected compounds.
    Toms LML; Bräunig J; Vijayasarathy S; Phillips S; Hobson P; Aylward LL; Kirk MD; Mueller JF
    Int J Hyg Environ Health; 2019 Apr; 222(3):387-394. PubMed ID: 30898527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal trends of per- and polyfluoroalkyl substances in children's serum.
    Koponen J; Winkens K; Airaksinen R; Berger U; Vestergren R; Cousins IT; Karvonen AM; Pekkanen J; Kiviranta H
    Environ Int; 2018 Dec; 121(Pt 1):591-599. PubMed ID: 30308470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population.
    Midasch O; Schettgen T; Angerer J
    Int J Hyg Environ Health; 2006 Nov; 209(6):489-96. PubMed ID: 16872899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.
    Toms LM; Thompson J; Rotander A; Hobson P; Calafat AM; Kato K; Ye X; Broomhall S; Harden F; Mueller JF
    Environ Int; 2014 Oct; 71():74-80. PubMed ID: 24980755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
    Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.